Global Bioidentical Hormones Market Size, Share, Forecast Report, 2020-2027

Bioidentical Hormones Market are biochemically the same as those made our body naturally, unlike conventional hormone therapy that uses synthetic hormones or animal-based hormones.

Bioidentical hormones are very similar to the hormones produced by the human body and are used as treatment for hormones deficiency. Bioidentical hormones are pre-made on prescription or are compounded by a pharmacist, based on the doctor’s demand. Bioidentical Hormones Market are most commonly used in the treatment of symptoms and associated complications of menopause such as hot flashes, night sweats, weight gain, mood changes, vaginal dryness, fatigue etc. Hormonal therapy however is beset with side effects such as increased risk of breast cancer, heart attack, stroke etc.

Bioidentical Hormones Market are somewhat controversial because they have not been approved by the U.S. Food and Drug Administration (FDA). The FDA approves of the individual ingredients used by compounding pharmacies but not the finished product. Prescription hormonal pharmaceuticals are FDA-regulated and guaranteed of same strength each time, while, compounded hormonal preparations of Bioidentical Hormones Market are not because they may contain different dosages due to batch to batch variations. Being unregulated , there is no guarantee of purity and safety as compared to conventional hormone products. The claims of Bioidentical Hormones Market being safer have not been supported by studies.

The market drivers for bioidentical hormones market are increasing geriatric population, growing screening for hormonal deficiency, rising awareness and growing income of women.

Key Players in the Global Bioidentical Hormones Market
Some of key players profiled in the global Bioidentical Hormones Market report are SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Inc., Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Biostation and others.